When I began practicing as an electrophysiologist in 1994, the dream of successfully using cardiac catheter ablation to ...
West Virginia residents experience disproportionately high instances of cardiovascular disease in comparison to other ...
At the 2017 Radiological Society of North America (RSNA) Annual Meeting, GE Healthcare and NVIDIA announced a series of imaging equipment advances powered by NVIDIA’s artificial intelligence (AI) computing platform. The announcements included the new Revolution Frontier computed tomography (CT) system, advancements to the Vivid E95 4-D Ultrasound and development of GE Healthcare’s Applied Intelligence analytics platform.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Vasorum Ltd, the developer and manufacturer of the novel Celt ACD vascular closure device, has added a 7F-sized Celt ACD device to its range following U.S. Food and Drug Administration (FDA) approval of its premarket approval (PMA) supplement. Celt ACD is indicated for arterial puncture closure in both diagnostic and interventional cardiology and radiology patients. Vasorum said the device offers excellent time to hemostasis in a wide variety of clinical situations. The second-generation Celt ACD devices now available in both the United States and Europe have a new improved delivery system which has been designed to enhance the user experience during deployment.
The U.S. Food and Drug Administration (FDA) announced clearance for NuMed’s Cheatham Platinum (CP) Stent System, which includes the Covered CP Stent and the Covered Mounted CP Stent. The Covered CP Stent is a metal framework covered with cloth to patch a blood vessel tear in patients born with heart defects. The device was approved previously to reopen a blocked or narrowed aorta.
December 14, 2017 — Siemens Healthineers introduced four new computed tomography (CT) scanners across two platforms at ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 13, 2017 — Toshiba Medical, a Canon Group company, introduced its new Aquilion Prime SP computed tomography (CT ...
Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug Administration (FDA) approval of the EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries. The EluNIR stent system is designed with a novel metallic spring tip and the narrowest strut width of any stent on the U.S. market, according to the companies, to help clinicians easily deliver this new DES in highly complex anatomy and disease.
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The diagnosis and management of cardiovascular disease has long followed a familiar approach. Patients see their ...
AI Visualize Inc. debuted its new cloud-based artificial intelligence (AI)-based image analysis and viewing platform at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. The technology relies on evolution and deep learning algorithms to assess imaging data for diagnostically valuable information not readily apparent through conventional analysis, and transmits detailed 3-D/2-D renderings to users on any internet-enabled device. The technology assists physicians in making the most of today’s data-intensive images for more accurate and precise diagnoses. The advanced interactive platform supports X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), 3-D tomosynthesis and digital pathology images, and provides a full range of relevant virtual image analysis tools.
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of radiofrequency (RF) coils that enables total freedom in coil positioning and handling during a magnetic resonance imaging (MRI) scan. The new coil design is 60 percent lighter than conventional coils, benefiting both patients and technologists, offers greater flexibility in all axes to help conform to patients’ anatomies and fits all patient ages, sizes and shapes.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Mayo Clinic researchers have shown a link between which type of oral anticoagulant a patient takes to prevent a stroke and increased risks of kidney function decline or failure.
VitalConnect Inc. announced its fifth 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company’s existing Class 2 wearable biosensor, the VitalPatch. This clearance extends the wear duration for the VitalPatch by 25 percent from 96 hours (four days) to 120 hours (five days).
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X Gradient, pending U.S. Food and Drug Administration (FDA) 510(k) clearance, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26 – Dec. 1 in Chicago. The Saturn X Gradient features an advanced strength of 45 mT/m (milliTesla per meter) to offer healthcare providers fast, higher-resolution imaging, while continuing to deliver streamlined workflow and patient comfort.